Health Canada suspends Grifols Winnipeg plasma site over compliance concerns
Advertisement
Read this article for free:
or
Already have an account? Log in here »
To continue reading, please subscribe:
Digital Subscription
One year of digital access for only $205*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*First annual payment billed as $205.00 + GST for one year. This annual subscription will automatically renew at $233.00 + GST every 52 weeks (10% off the regular annual price of $259.35). Offer available to new and qualified returning subscribers only. Cancel any time.
To continue reading, please subscribe:
Add Free Press access to your Brandon Sun subscription for only an additional
$1 for the first 4 weeks*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Your next Brandon Sun subscription payment will increase by $1.00 and you will be charged $17.95 plus GST for four weeks. After four weeks, your payment will increase to $24.95 plus GST every four weeks.
Read unlimited articles for free today:
or
Already have an account? Log in here »
WINNIPEG – Health Canada has suspended all collections at a plasma donation centre in Winnipeg that had been part of an investigation into two donor deaths.
Health Canada began investigating earlier this year after two donors died, each at a separate Grifols location in Winnipeg.
No link was found between the deaths of the plasma donors and the collection process, but Health Canada found compliance problems at Grifols’ Taylor Avenue location.
In August, Grifols voluntarily suspended plasma collection anyway, citing what it called “unfounded attention” on its practices.
Health Canada, however, has now slapped its own plasma collection ban on Grifols’ Taylor Avenue location, saying that site has failed to shore up clinic practices as directed.
Grifols, a private company based in Spain, could not immediately be reached for comment.
Health Canada said in a statement Wednesday it “will continue to work with Grifols as it seeks to resume activities and implement corrective action plans.”
This report by The Canadian Press was first published Sept. 23, 2026.